Daniel Vu, MD
Daniel Vu, MD
Physician and Surgeon
About Daniel Vu, MD
Dr. Vu is a member of the Glaucoma Service, who specializes in both adult and pediatric glaucoma at Mass. Eye and Ear and Boston Children’s Hospital. He completed his fellowship at Bascom Palmer Eye Institute, where he received additional training in pediatric glaucoma management and surgery. He performs both traditional and minimally invasive glaucoma surgeries, as well as laser treatments for glaucoma. His research interests include improving the understanding and diagnostic imaging capabilities on aqueous outflow pathways in childhood glaucoma.
Clinical Interests:
- Glaucoma
- Cataract
- Ophthalmology
Treats:
- Adult
Locations
Massachusetts Eye and Ear Infirmary
243 Charles Street
Boston, MA 02114 - 3002
Phone: 617-523-7900
Mass Eye and Ear Longwood
800 Huntington Avenue
Boston, MA 02115-6303
Phone: 617-936-6156
Fax: 617-936-6186
Massachusetts Eye and Ear Stoneham
1 Montvale Avenue
Suite 501
Stoneham, MA 02180
Phone: 781-279-4418
Fax: 617-573-5607
Medical Education
- MD, Weill Cornell Medical College
- Residency, Duke University Eye Center
- Fellowship, Bascom Palmer Eye Institute
Accepted Insurance Plans
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Harvard Pilgrim Health Plan - other
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Vu’s research uses diagnostic imaging technology on aqueous outflow channels in order to identify areas of impaired drainage in glaucoma and improve visualization for surgical techniques that target the iridocorneal angle. He is also a collaborator in the Childhood Glaucoma Research Network, an international group of pediatric glaucoma specialists that focuses on improving the diagnosis and management of children with glaucoma through large multicenter studies. The goal of his research is to improve the long-term outcomes for patients with this blinding disease.